Biogen says Tecfidera data confirms efficacy
Biogen says Tecfidera data confirms efficacy
Biogen has unveiled new Tecfidera research that, it says, reinforces its efficacy in newly diagnosed relapsing-remitting multiple sclerosis (RRMS) patients and further supports its long-term, well-characterised safety profile. The data was presented at the 68th annual meeting of the American Academy of Neurology (AAN) in Vancouver, Canada...Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post